ArticleBlood cell therapy2024

Long-term remissions with Gilteritinib in early relapse after allogeneic stem cell transplantation of FLT3/NPM1 mutated acute myeloid leukemia.

E Tamellini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.